Everence Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,183
Closed -$458K 942
2026
Q1
$458K Buy
4,183
+272
+7% +$38.7K 0.03% 404
2025
Q4
$651K Hold
3,911
0.04% 319
2025
Q3
$766K Sell
3,911
-399
-9% -$65.6K 0.05% 288
2025
Q2
$390K Buy
+4,310
New +$341K 0.03% 463
2025
Q1
Sell
-3,870
Closed -$513K 861
2024
Q4
$513K Buy
+3,870
New +$363K 0.03% 357

Other funds holding ALAB

Everence Capital Management's ALAB Position: Q2 2026 in Review

Everence Capital Management sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 4,183 shares — an estimated $458K sold.

Everence Capital Management first reported a position in ALAB in Q4 2024 and held it in 5 quarters. The position peaked at $766K in Q3 2025. 991 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Everence Capital Management reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • Everence Capital Management sold 4,183 Astera Labs shares in Q2 2026, an estimated $458K.
  • Everence Capital Management first reported a position in Astera Labs in Q4 2024 and held it in 5 quarters.
  • Everence Capital Management's Astera Labs position peaked at $766K in Q3 2025.
  • 991 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.